2020
DOI: 10.1002/jmv.26478
|View full text |Cite
|
Sign up to set email alerts
|

Questions concerning the proximal origin of SARS‐CoV‐2

Abstract: tropism/adaptation, resistance to neutralizing antibodies, or immune evasion. 2 Interestingly, clinical SARS-CoV-2 isolates to date have only a single high-frequency nonsynonymous mutation, D614G, in their S protein. 9 Based on currently known mutation rates and patterns in clinical isolates of SARS-CoV-2, the S protein does not appear to be a mutational "hot spot" for SARS-CoV-2, unlike other human CoVs. SARS-CoV-2 is the seventh HCoV, but the first HCoV with pandemic potential. SARS-CoV disappeared without a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
53
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 67 publications
(54 citation statements)
references
References 9 publications
1
53
0
Order By: Relevance
“…Overall, the CD200 was identified by both sequencing the complete genomes (NGS) and the partial RT-PCR (Sanger sequencing) fragment in eight out of 12 EriCoVs tested. This finding is consistent with a template-switching mechanism deemed to underlie the high rate of RNA recombination in CoVs and consequently to represent a possible mechanism at the origin of recombinant CoVs including other CoV or even host related sequences [ 27 , 28 ].…”
Section: Discussionsupporting
confidence: 81%
“…Overall, the CD200 was identified by both sequencing the complete genomes (NGS) and the partial RT-PCR (Sanger sequencing) fragment in eight out of 12 EriCoVs tested. This finding is consistent with a template-switching mechanism deemed to underlie the high rate of RNA recombination in CoVs and consequently to represent a possible mechanism at the origin of recombinant CoVs including other CoV or even host related sequences [ 27 , 28 ].…”
Section: Discussionsupporting
confidence: 81%
“…This indicates that the bat virus is capable of counteracting the human immune defenses, which may have facilitated successful zoonotic transmission from bat eventually to humans. Currently, the intermediate animal host of SARS-CoV-2 is under debate 3,6870 , however it is likely, that the virus isolated from it is even closer related to SARS-CoV-2 than RATG13. Thus, any immune evasion mechanisms conserved between SARS-CoV-2 and RATG13, is likely to be conserved in the direct progenitor virus of SARS-CoV-2.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is possible to exclude that such insertion could have originated by polymerase slippage or by releasing and repriming, because insertion mutations generated by these mechanisms have been postulated to maintain the reading frame of the viral sequence. [ 46 ] The possibility that the furin cleavage site could have been acquired by recombination has been recently questioned by Seyran et al., [ 47 ] because the SARS‐CoV‐2 spike protein seems to lack any further recombination event in contrast with the recombination model of other CoVs.…”
Section: The Furin Cleavage Site: the Key Difference Between Sars‐covmentioning
confidence: 99%